145 related articles for article (PubMed ID: 15563761)
21. Pharmacokinetics, blood partition and protein binding of DA-7867, a new oxazolidinone.
Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2004 Apr; 25(3):127-35. PubMed ID: 15083501
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours.
Bae SK; Lee SJ; Kim JW; Kim YH; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 Mar; 26(2):77-83. PubMed ID: 15617135
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats.
Chung HJ; Choi YH; Choi HD; Jang JM; Shim HJ; Yoo M; Kwon JW; Lee MG
Eur J Pharm Sci; 2006 Mar; 27(4):363-74. PubMed ID: 16387482
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
Shin HS; Bae SK; Lee MG
Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145
[TBL] [Abstract][Full Text] [Related]
25. Effects of cysteine on the pharmacokinetics of intravenous clarithromycin in rats with protein-calorie malnutrition.
Ahn CY; Kim EJ; Kwon JW; Chung SJ; Kim SG; Shim CK; Lee MG
Life Sci; 2003 Aug; 73(14):1783-94. PubMed ID: 12888117
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous and oral administration of mirodenafil to streptozotocin-induced diabetes mellitus rats.
Lee YS; Choi YH; Kim TK; Ryu KH; Lee BY; Lee MG
Xenobiotica; 2010 Feb; 40(2):129-37. PubMed ID: 19929308
[TBL] [Abstract][Full Text] [Related]
27. Gender differences in the pharmacokinetics of DA-6034, a derivative of flavonoids, in rats.
Yang SH; Bae SK; Kwon JW; Yoo M; Lee MG
Biopharm Drug Dispos; 2006 Jan; 27(1):47-51. PubMed ID: 16302288
[TBL] [Abstract][Full Text] [Related]
28. Hepatic and intestinal first-pass effects of oltipraz in rats.
Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic interaction between oltipraz and dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) after single intravenous and oral administration to rats.
Bae SK; Kim EJ; Chung SJ; Kim SG; Lee MG
J Pharm Pharmacol; 2003 Sep; 55(9):1241-9. PubMed ID: 14604467
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.
Bae SK; Yang SH; Lee SJ; Kwon JW; Kim WB; Lee DC; Lee MG
Eur J Pharm Sci; 2005 Jun; 25(2-3):337-45. PubMed ID: 15911231
[TBL] [Abstract][Full Text] [Related]
31. Effects of neostigmine on the pharmacokinetics of intravenous parathion in rats.
Hurh E; Lee EJ; Kim YG; Kim SY; Kim SH; Kim YC; Lee MG
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):261-73. PubMed ID: 11913717
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
Han KS; Lee MG
Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
[TBL] [Abstract][Full Text] [Related]
33. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
Yu SY; Chung HC; Kim EJ; Kim SH; Lee I; Kim SG; Lee MG
J Pharm Pharmacol; 2002 Dec; 54(12):1687-92. PubMed ID: 12542900
[TBL] [Abstract][Full Text] [Related]
34. Cysteine effects on the pharmacokinetics of etoposide in protein-calorie malnutrition rats: increased gastrointestinal absorption by cysteine.
Suh JH; Kang HE; Yoon IS; Yang SH; Kim SH; Lee HJ; Shim CK; Lee MG
Xenobiotica; 2011 Oct; 41(10):885-94. PubMed ID: 21623701
[TBL] [Abstract][Full Text] [Related]
35. Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein-calorie malnutrition.
Bae SK; Lee DY; Lee AK; Kwon JW; Lee I; Chung SJ; Kim SG; Shim CK; Lee MG
J Pharm Sci; 2004 Sep; 93(9):2388-98. PubMed ID: 15295798
[TBL] [Abstract][Full Text] [Related]
36. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA-8159, a new erectogenic, in rats.
Kim YC; Shim HJ; Lee JH; Kim SH; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2005 Sep; 26(6):233-41. PubMed ID: 15926192
[TBL] [Abstract][Full Text] [Related]
37. Effects of cysteine on the pharmacokinetics of itraconazole in rats with protein-calorie malnutrition.
Lee AK; Ahn CY; Kim EJ; Kwon JW; Kim SG; Chung SJ; Shim CK; Lee MG
Biopharm Drug Dispos; 2003 Mar; 24(2):63-70. PubMed ID: 12619051
[TBL] [Abstract][Full Text] [Related]
38. Effects of cysteine on the pharmacokinetics of intravenous 2-(allylthio)pyrazine, a new chemoprotective agent, in rats with protein-calorie malnutrition.
Yim YG; Cho MK; Kwon JW; Kim DH; Kim SG; Lee MG
Int J Pharm; 2003 Apr; 255(1-2):1-11. PubMed ID: 12672597
[TBL] [Abstract][Full Text] [Related]
39. Dose-dependent pharmacokinetics of KR-31378, a new neuroprotective agent for ischaemia-reperfusion damage in dogs.
Kim SO; Kwak SH; Lee BH; Lee DH; Lim H; Yoo SE; Chung HJ; Lee MG
Biopharm Drug Dispos; 2004 Apr; 25(3):143-8. PubMed ID: 15083503
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability.
Chung HJ; Lee JH; Woo SJ; Park HK; Koo CH; Lee MG
Biopharm Drug Dispos; 2007 May; 28(4):187-97. PubMed ID: 17377948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
